StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) bonds

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Debt

Borrowings on the balance sheet, Dec 31, 2025

Total debt
$1.65B
$0 due within a year
Net debt
$815.42M
After $839.01M of cash
Implied interest rate
2.18%
FY2025 interest ÷ average debt
Interest coverage
14.0×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Qiagen's 20-F for the period ended Dec 31, 2025

IssueCouponMaturesAmount issuedCarrying value
0.000% Senior Unsecured Convertible Notes due 2027
Convertible at $81 a share
0.00%2027$26.00M$26.00M
2.500% Senior Unsecured Convertible Notes due 2031
Convertible at $64 a share
2.50%2031$500.00M$495.25M
2.000% Senior Unsecured Convertible Notes due 2032
Convertible at $65 a share
2.00%2032$750.00M$742.39M
German Private Placement (2017 Schuldschein)––$17.04M$17.03M
German Private Placement (2022 Schuldschein)––$374.23M$373.75M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 20-F.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
ESG-Linked Revolving Credit Facility€400.00M
Line of Credit€13.00M
Line of Credit$8.20M

See a number that looks wrong?